Loading...

Nachrichtenliste

Nachrichtenliste

Novartis‘s Multiple sclerosis Innovative drug approved

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for th

Erfahren Sie mehr 2019-03-29
Highly efficient trifluoromethylation and [18F]trifluoromethylation

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, ha

Erfahren Sie mehr 2019-03-01
Redox neutral [4+1] cyclic reaction based on C-F fracture

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Techno

Erfahren Sie mehr 2019-01-18
FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a c

Erfahren Sie mehr 2018-12-14
FDA approves new mechanism for listing new anti-influenza drugs

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil)

Erfahren Sie mehr 2018-11-16
FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate o

Erfahren Sie mehr 2018-10-20
For the first time, scientists have discovered fluorine in natural conditions

Fluorine is the most reactive chemical element. That is why it is not found in nature in its element

Erfahren Sie mehr 2018-09-20
Fluorinated antimalarial drug tafenoquine (Krintafel) approved by the US FDA

Recently, British pharmaceutical giant GlaxoSmithKline (GSK) announced that the fluorogenic anti-mal

Erfahren Sie mehr 2018-08-14
Sanofi is approved the listing of rare disease drugs in China

Sanofi is approved in China for the treatment of a new drug for relapsing multiple sclerosis, Obajie

Erfahren Sie mehr 2018-07-29
Why can fluorine-substituted conjugated polymers improve the efficiency of organic solar cells?

Today, with the increasing consumption of energy, research on solar cells has attracted more and mor

Erfahren Sie mehr 2018-07-15